105 related articles for article (PubMed ID: 17681967)
1. Estimation of the plasma effect-site equilibration rate constant (ke0) of rocuronium by the time of maximum effect: a comparison with non-parametric and parametric approaches.
Cortínez LI; Nazar C; Muñoz HR
Br J Anaesth; 2007 Nov; 99(5):679-85. PubMed ID: 17681967
[TBL] [Abstract][Full Text] [Related]
2. [Reevaluation of the time course of the effect of propofol described with the Schnider pharmacokinetic model].
Sepúlveda PO; Mora X
Rev Esp Anestesiol Reanim; 2012 Dec; 59(10):542-8. PubMed ID: 23040653
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children.
Wierda JM; Meretoja OA; Taivainen T; Proost JH
Br J Anaesth; 1997 Jun; 78(6):690-5. PubMed ID: 9215021
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.
van Miert MM; Eastwood NB; Boyd AH; Parker CJ; Hunter JM
Br J Clin Pharmacol; 1997 Aug; 44(2):139-44. PubMed ID: 9278198
[TBL] [Abstract][Full Text] [Related]
5. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
Woloszczuk-Gebicka B; Wyska E; Grabowski T
Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
[TBL] [Abstract][Full Text] [Related]
6. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
[TBL] [Abstract][Full Text] [Related]
7. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
[TBL] [Abstract][Full Text] [Related]
8. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependency of pharmacokinetic/pharmacodynamic parameters after intravenous bolus doses of cisatracurium.
Chen C; Yamaguchi N; Varin F
Br J Anaesth; 2008 Dec; 101(6):788-97. PubMed ID: 18974056
[TBL] [Abstract][Full Text] [Related]
12. A comparison between bispectral index analysis and auditory-evoked potentials for monitoring the time to peak effect to calculate the plasma effect site equilibration rate constant of propofol.
Zhang MZ; Yu Q; Huang YL; Wang SJ; Wang XR
Eur J Anaesthesiol; 2007 Oct; 24(10):876-81. PubMed ID: 17583594
[TBL] [Abstract][Full Text] [Related]
13. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
Stout RG; Shine TS; Silverman DG; Brull SJ
Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
[TBL] [Abstract][Full Text] [Related]
14. Monitoring recovery from rocuronium-induced neuromuscular block using acceleromyography at the trapezius versus the adductor pollicis muscle: an observational trial.
Soltesz S; Stark C; Noé KG; Anapolski M; Mencke T
Can J Anaesth; 2016 Jun; 63(6):709-17. PubMed ID: 26864194
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
[TBL] [Abstract][Full Text] [Related]
16. Prediction of infusion rates of rocuronium using the bolus test dose technique.
Harrison MJ
Anaesthesia; 1997 Jan; 52(1):37-40. PubMed ID: 9014543
[TBL] [Abstract][Full Text] [Related]
17. Influence of acute normovolaemic haemodilution on the dose-response relationship, time-course of action and pharmacokinetics of rocuronium bromide.
Dahaba AA; Perelman SI; Moskowitz DM; Bennett HL; Shander A; Oettl K; Reibnegger G; Metzler H
Br J Anaesth; 2006 Oct; 97(4):482-8. PubMed ID: 16873389
[TBL] [Abstract][Full Text] [Related]
18. The effects of age on maintenance of intense neuromuscular block with rocuronium.
Furuya T; Suzuki T; Kashiwai A; Konishi J; Aono M; Hirose N; Kato J; Ogawa S
Acta Anaesthesiol Scand; 2012 Feb; 56(2):236-9. PubMed ID: 22236347
[TBL] [Abstract][Full Text] [Related]
19. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients.
Sparr HJ; Wierda JM; Proost JH; Keller C; Khuenl-Brady KS
Br J Anaesth; 1997 Mar; 78(3):267-73. PubMed ID: 9135303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
